Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention—prospective, single-center, randomized, parallel-group study

Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention—prospective, single-center, randomized, parallel-group study

Abstract Background The data on bosentan were lacking for the treatment of exercise-induced elevation of pulmonary artery pressure (eePAP) or less severe PH in COPD. This study was conducted to investigate long-term efficacy and safety of bosentan for the treatment of eePAP or less severe PH in COPD...

Full description

Bibliographic Details
Main Authors: Takeru Kashiwada, Yosuke Tanaka, Toru Tanaka, Tetsuya Okano, Yoshinobu Saito, Masahiro Seike, Mitsunori Hino, Hiroshi Kimura, Akihiko Gemma
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Pulmonary Medicine
Subjects:
Pulmonary hypertension
COPD
Right heart catheterization
Echocardiography
Endothelin receptor antagonists
Online Access:https://doi.org/10.1186/s12890-024-02895-0

Internet

https://doi.org/10.1186/s12890-024-02895-0

Similar Items